
M1 Kliniken AG
XETRA:M12

M1 Kliniken AG?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
13.35
21.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does M1 Kliniken AG hold over its rivals?
What risks and challenges
does M1 Kliniken AG face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of M1 Kliniken AG.
Provide an overview of the primary business activities
of M1 Kliniken AG.
What unique competitive advantages
does M1 Kliniken AG hold over its rivals?
What risks and challenges
does M1 Kliniken AG face in the near future?
Has there been any significant insider trading activity
in M1 Kliniken AG recently?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for M1 Kliniken AG.
Provide P/S
for M1 Kliniken AG.
Provide P/E
for M1 Kliniken AG.
Provide P/OCF
for M1 Kliniken AG.
Provide P/FCFE
for M1 Kliniken AG.
Provide P/B
for M1 Kliniken AG.
Provide EV/S
for M1 Kliniken AG.
Provide EV/GP
for M1 Kliniken AG.
Provide EV/EBITDA
for M1 Kliniken AG.
Provide EV/EBIT
for M1 Kliniken AG.
Provide EV/OCF
for M1 Kliniken AG.
Provide EV/FCFF
for M1 Kliniken AG.
Provide EV/IC
for M1 Kliniken AG.
Show me price targets
for M1 Kliniken AG made by professional analysts.
What are the Revenue projections
for M1 Kliniken AG?
How accurate were the past Revenue estimates
for M1 Kliniken AG?
What are the Net Income projections
for M1 Kliniken AG?
How accurate were the past Net Income estimates
for M1 Kliniken AG?
What are the EPS projections
for M1 Kliniken AG?
How accurate were the past EPS estimates
for M1 Kliniken AG?
What are the EBIT projections
for M1 Kliniken AG?
How accurate were the past EBIT estimates
for M1 Kliniken AG?
Compare the revenue forecasts
for M1 Kliniken AG with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of M1 Kliniken AG and its key competitors using the latest financial data.
Compare historical revenue growth rates
of M1 Kliniken AG against its competitors.
Analyze the profit margins
(gross, operating, and net) of M1 Kliniken AG compared to its peers.
Compare the P/E ratios
of M1 Kliniken AG against its peers.
Discuss the investment returns and shareholder value creation
comparing M1 Kliniken AG with its peers.
Analyze the financial leverage
of M1 Kliniken AG compared to its main competitors.
Show all profitability ratios
for M1 Kliniken AG.
Provide ROE
for M1 Kliniken AG.
Provide ROA
for M1 Kliniken AG.
Provide ROIC
for M1 Kliniken AG.
Provide ROCE
for M1 Kliniken AG.
Provide Gross Margin
for M1 Kliniken AG.
Provide Operating Margin
for M1 Kliniken AG.
Provide Net Margin
for M1 Kliniken AG.
Provide FCF Margin
for M1 Kliniken AG.
Show all solvency ratios
for M1 Kliniken AG.
Provide D/E Ratio
for M1 Kliniken AG.
Provide D/A Ratio
for M1 Kliniken AG.
Provide Interest Coverage Ratio
for M1 Kliniken AG.
Provide Altman Z-Score Ratio
for M1 Kliniken AG.
Provide Quick Ratio
for M1 Kliniken AG.
Provide Current Ratio
for M1 Kliniken AG.
Provide Cash Ratio
for M1 Kliniken AG.
What is the historical Revenue growth
over the last 5 years for M1 Kliniken AG?
What is the historical Net Income growth
over the last 5 years for M1 Kliniken AG?
What is the current Free Cash Flow
of M1 Kliniken AG?
Discuss the annual earnings per share (EPS)
trend over the past five years for M1 Kliniken AG.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
DE |
![]() |
M1 Kliniken AG
XETRA:M12
|
296.3m EUR | 8.8 | |
US |
![]() |
HCA Healthcare Inc
NYSE:HCA
|
93.9B USD | 9.4 |
|
SA |
![]() |
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 35.6 |
|
ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
20.8B Zac | 0 |
|
ZA |
N
|
Netcare Ltd
JSE:NTC
|
19.7B Zac | 0 |
|
CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
117.7B CNY | 25.3 |
|
US |
![]() |
Tenet Healthcare Corp
NYSE:THC
|
16B USD | 6.2 |
|
MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
60.6B MYR | 12.1 |
|
BR |
![]() |
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
80B BRL | 7.8 |
|
IN |
![]() |
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
1.1T INR | 64.8 |
|
US |
![]() |
Encompass Health Corp
NYSE:EHC
|
12.2B USD | 11.7 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
DE |
![]() |
M1 Kliniken AG
XETRA:M12
|
Average EV/EBITDA:
20.2
8.8
|
26%
|
0.3 | |
US |
![]() |
HCA Healthcare Inc
NYSE:HCA
|
9.4
|
6%
|
1.6 |
|
SA |
![]() |
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
35.6
|
19%
|
1.9 |
|
ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
Not Available |
7%
|
N/A |
|
ZA |
N
|
Netcare Ltd
JSE:NTC
|
Not Available |
19%
|
N/A |
|
CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
25.3
|
25%
|
1 |
|
US |
![]() |
Tenet Healthcare Corp
NYSE:THC
|
6.2
|
5%
|
1.2 |
|
MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
12.1
|
7%
|
1.7 |
|
BR |
![]() |
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
7.8
|
15%
|
0.5 |
|
IN |
![]() |
Max Healthcare Institute Ltd
NSE:MAXHEALTH
|
64.8
|
33%
|
2 |
|
US |
![]() |
Encompass Health Corp
NYSE:EHC
|
11.7
|
7%
|
1.7 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.